Monitor for potential downward pressure ahead of next earnings or lack of catalysts; consider whether this selling follows a pattern of post-earnings or vesting-date transactions. The CEO's sale is particularly concerning given size and timing relative to grants.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 4 $79.47entry
- T+1 · 9mo ago +3.18%α +3.76% · $82.00
- T+5 · 8mo ago +7.08%α +8.42% · $85.10
- T+20 · 8mo ago −17.55%α −13.14% · $65.52
- T+60 · 6mo ago −36.89%α −46.98% · $50.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GeneDx CEO Katherine Stueland sold $455K in open-market shares while receiving a large non-cash stock award; CFO Kevin Feeley sold $110K and received non-cash grants. The cluster is dominated by routine compensation grants, but the CEO's open-market sale is the largest transaction and suggests potential lack of conviction.
Key Financial Metrics
Key Facts
- CEO Katherine Stueland sold 5,861 shares at $77.63, totaling $454,967 in open-market transaction
- CFO Kevin Feeley sold 1,424 shares for $110,540 in open-market trade
- CEO and CFO received substantial non-cash stock awards totaling 107,469 shares collectively, valued at $299,926 for the CEO's time-based grant
- Total open-market selling: $565,507 (CEO: $455K, CFO: $110.5K)
- Open-market sales represent ~0.022% of $2.6B market cap, modest but notable given C-suite participation
Financial Impact
$565,507 in net open-market selling by C-suite executives
Risk Factors
- Insider selling may signal lack of confidence in near-term prospects
- Potential for negative market perception despite routine nature of grants
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-WGS-1773057319627 |
Track record
13 reports on WGS
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +63.51% at T+60 after the May 20, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $52.37 Now $51.02 −2.58% settles Feb 11
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $54.83 Now $51.02 −6.95% settles Feb 8
- Nov 6, 202610d ago SC 13G Neutral 3/10 Entry $62.37 Now $51.02 −18.20% settles Feb 4
- Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $97.83 Now $51.02 +47.85% settles Dec 15
- Sep 11, 20269w ago Insider Cluster Neutral 2/10 Entry $89.74 Now $51.02 −43.15% settles Dec 8
- Sep 1, 202610w ago 144 Neutral 2/10 Entry $86.72 Now $51.02 −41.17% settles Nov 27
- Jun 16, 202621w ago 8-K Neutral 3/10 Entry $60.60 to $83.96 Now $51.02 −15.81% ▲ +38.55% +37.55% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 4/10 Entry $59.92 to $85.87 Now $51.02 −14.85% ▲ +43.31% +40.04% vs SPY
- Jun 8, 202623w ago Insider Cluster Bullish 6/10 Entry $56.33 to $86.72 Now $51.02 −9.43% ▲ +53.95% +50.14% vs SPY
- May 20, 202625w ago Insider Cluster Bullish 6/10 Entry $47.33 to $77.39 Now $51.02 +7.80% ▲ +63.51% +59.21% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers